Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma.
Yu H, Liu R, Ma B, Li X, Yen HY, Zhou Y, Krasnoperov V, Xia Z, Zhang X, Bove AM, Buscarini M, Parekh D, Gill IS, Liao Q, Tretiakova M, Quinn D, Zhao J, Gill PS.
Yu H, et al. Among authors: ma b.
Br J Cancer. 2015 Aug 11;113(4):616-25. doi: 10.1038/bjc.2015.237. Epub 2015 Jul 16.
Br J Cancer. 2015.
PMID: 26180925
Free PMC article.